Molecular Fingerprint Detection Using Portable Water‐Compatible Electronic Tunneling Spectroscopy Device

2020 ◽  
Vol 7 (19) ◽  
pp. 2000605
Author(s):  
Prajith Karadan ◽  
Amir Ziv ◽  
Avra Tzaguy ◽  
Shira Yochelis ◽  
Yossi Paltiel ◽  
...  
Author(s):  
Seyed Hadi Badri ◽  
Mohsen Mohammadzadeh Gilarlue ◽  
Sanam Nahaie ◽  
Jong Su Kim

2020 ◽  
Vol 45 (8) ◽  
pp. 2335
Author(s):  
Jinfeng Zhu ◽  
Shan Jiang ◽  
Yinong Xie ◽  
Fajun Li ◽  
Lianghui Du ◽  
...  

2004 ◽  
Vol 114 ◽  
pp. 135-136 ◽  
Author(s):  
E. Slot ◽  
K. O'Neill ◽  
H. S.J. van der Zant ◽  
R. E. Thorne

2001 ◽  
Vol 171 (12) ◽  
pp. 1368
Author(s):  
V.A. Volkov ◽  
E.E. Takhtamirov ◽  
D.Yu. Ivanov ◽  
Yu.V. Dubrovskii ◽  
L. Eaves ◽  
...  

2003 ◽  
Vol 771 ◽  
Author(s):  
M. Kemerink ◽  
S.F. Alvarado ◽  
P.M. Koenraad ◽  
R.A.J. Janssen ◽  
H.W.M. Salemink ◽  
...  

AbstractScanning-tunneling spectroscopy experiments have been performed on conjugated polymer films and have been compared to a three-dimensional numerical model for charge injection and transport. It is found that field enhancement near the tip apex leads to significant changes in the injected current, which can amount to more than an order of magnitude, and can even change the polarity of the dominant charge carrier. As a direct consequence, the single-particle band gap and band alignment of the organic material can be directly obtained from tip height-voltage (z-V) curves, provided that the tip has a sufficiently sharp apex.


2020 ◽  
Vol 27 ◽  
Author(s):  
Maria V. Deligiorgi ◽  
Mihalis I. Panayiotidis ◽  
Gerasimos Siasos ◽  
Dimitrios T. Trafalis

: Beyond being epiphenomenon of shared epidemiological factors, the integration of osteoporosis (OP) with cardiovascular disease (CVD)− termed "calcification paradox"− reflects a continuum of aberrant cardiometabolic status. The present review provides background knowledge on "calcification paradox", focusing on the endocrine aspect of vasculature orchestrated by the osteoblastic molecular fingerprint of vascular cells, acquired via imbalance among established modulators of mineralization. Osteoprotegerin (OPG)–the well-established osteoprotective cytokine−has recently been shown to exert a vessel-modifying role. Prompted by this notion, the present review interrogates OPG as the potential missing link between OP and CVD. However, so far, the confirmation of this hypothesis is hindered by the equivocal role of OPG in CVD, being both proatherosclerotic and antiatherosclerotic. Further research is needed to illuminate whether OPG could be biomarker of the "calcification paradox". Moreover, the present review brings into prominence the dual role of statins−cardioprotective and osteoprotective− as potential illustration of the integration of CVD with OP. Considering that the statins-induced modulation of OPG is central to the statins-driven osteoprotective signalling, statins could be suggested as illustration of the role of OPG in the bone/vessels crosstalk, if further studies consolidate the contribution of OPG to the cardioprotective role of statins. Another outstanding issue that merits further evaluation is the inconsistency of the osteoprotective role of statins. Further understanding of the varying bone-modifying role of statins, likely attributed to the unique profile of different classes of statins defined by distinct physicochemical characteristics, may yield tangible benefits for treating simultaneously OP and CVD.


Sign in / Sign up

Export Citation Format

Share Document